Try our Advanced Search for more refined results
USA v. Shkreli et al
Case Number:
1:15-cr-00637
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
March 07, 2018
Shkreli Attys Call 15-Year Sentence 'Severe,' Ask For 1.5
Martin Shkreli's attorneys called the government's recommendation of 15 years prison time for securities fraud "far too severe" in a letter to a New York federal judge on Wednesday, arguing that a sentence of 18 months or less would be more appropriate for the controversial former pharmaceutical executive's crimes.
-
March 06, 2018
Feds Seek 15-Year Term For Martin Shkreli
Federal prosecutors on Tuesday asked a New York federal judge to sentence Martin Shkreli to 15 years in prison for defrauding his hedge fund investors and for market manipulation, calling the controversial former pharmaceutical executive a remorseless liar driven by pure greed.
-
March 05, 2018
Shkreli Must Give Up $7.3M, Wu-Tang Clan Album
Former biotech CEO Martin Shkreli must forfeit more than $7.3 million stemming from his conviction for securities fraud and conspiracy, a New York federal judge said Monday, rejecting arguments from the "pharma bro" that not all the money was tied to an illicit scheme.
-
February 28, 2018
Shkreli Argues For Short Prison Stint Ahead Of Sentencing
Martin Shkreli asked a New York federal judge on Tuesday to spare him a long prison sentence for his securities fraud conviction, arguing that a year to 18 months behind bars, coupled with community service and therapy, would be just punishment for his wrongdoing and erratic behavior.
-
February 26, 2018
Shkreli Caused $10.4M In Losses, Not Zero, Judge Rules
A Brooklyn federal judge slated to sentence Martin Shkreli following his conviction for an investment fraud scheme ruled Monday that he will be held to account for $10.4 million in losses, rejecting Shkreli's argument that investors didn't lose anything and increasing the likelihood he will face a lengthy prison term.
-
February 23, 2018
Shkreli Can't Beat Stock Fraud Rap Post-Trial
A New York federal judge on Friday refused a request by former pharmaceutical executive Martin Shkreli to throw out his conviction for manipulating the stock of Retrophin Inc. while he was its CEO, saying there was sufficient evidence for the jury to find him guilty.
-
February 20, 2018
Ex-Katten Muchin Atty Says Jury Misconduct Tainted Trial
Attorneys for former Katten Muchin Rosenman LLP partner Evan Greebel on Saturday gave the most detailed account to date of a raft of purported jury misconduct they say plagued the trial of the onetime attorney to Martin Shkreli, arguing that Greebel's conviction should be quashed.
-
February 12, 2018
Shkreli Seeks Light Sentence, Saying His Victims Profited
Former pharmaceutical company executive and hedge fund manager Martin Shkreli on Friday urged a Brooklyn federal judge to find that he didn't harm investors or even intend to cause losses, despite his conviction for securities fraud, saying that many investors actually profited from his hard work.
-
January 31, 2018
Shkreli Sentencing Delayed While Parties Mull Loss, Forfeiture
Former pharmaceutical executive and convicted fraudster Martin Shkreli on Wednesday had his sentencing pushed off for another two weeks so his lawyers and the federal government can make their cases for how much investors lost and how much he gained from criminal wrongdoing.
-
January 12, 2018
Shkreli Hits Back At Feds' $7.3M Forfeiture Bid
Controversial former pharmaceutical executive Martin Shkreli urged a New York federal judge Thursday to reject the government's demands that he forfeit $7.3 million following his August conviction on securities fraud and conspiracy charges, arguing that he made no profit from the alleged crimes.